GB202010573D0 - Formulation - Google Patents
FormulationInfo
- Publication number
- GB202010573D0 GB202010573D0 GBGB2010573.0A GB202010573A GB202010573D0 GB 202010573 D0 GB202010573 D0 GB 202010573D0 GB 202010573 A GB202010573 A GB 202010573A GB 202010573 D0 GB202010573 D0 GB 202010573D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2010573.0A GB202010573D0 (en) | 2020-07-09 | 2020-07-09 | Formulation |
US17/097,898 US11045434B1 (en) | 2020-04-01 | 2020-11-13 | Niclosamide formulations for treating disease |
CA3172166A CA3172166A1 (en) | 2020-04-01 | 2021-03-26 | Formulation |
PCT/EP2021/058047 WO2021198116A1 (en) | 2020-04-01 | 2021-03-26 | Formulation |
JP2022560085A JP2023520229A (en) | 2020-04-01 | 2021-03-26 | pharmaceutical formulation |
KR1020227038253A KR20230024883A (en) | 2020-04-01 | 2021-03-26 | formulation |
BR112022019521A BR112022019521A2 (en) | 2020-04-01 | 2021-03-26 | FORMULATION |
US17/995,053 US20230190685A1 (en) | 2020-04-01 | 2021-03-26 | Formulation |
US17/995,079 US20230147683A1 (en) | 2020-04-01 | 2021-03-26 | Treatment |
CA3173163A CA3173163A1 (en) | 2020-04-01 | 2021-03-26 | Treatment |
MX2022012359A MX2022012359A (en) | 2020-04-01 | 2021-03-26 | Formulation. |
CN202180036954.6A CN115701984A (en) | 2020-04-01 | 2021-03-26 | Treatment of |
EP21715583.7A EP4125805A1 (en) | 2020-04-01 | 2021-03-26 | Formulation |
AU2021248603A AU2021248603A1 (en) | 2020-04-01 | 2021-03-26 | Treatment |
JP2022560369A JP2023520542A (en) | 2020-04-01 | 2021-03-26 | therapeutic drug |
CN202180035793.9A CN115701983A (en) | 2020-04-01 | 2021-03-26 | Formulations |
MX2022012360A MX2022012360A (en) | 2020-04-01 | 2021-03-26 | Treatment. |
KR1020227038248A KR20230020952A (en) | 2020-04-01 | 2021-03-26 | therapy |
AU2021247378A AU2021247378A1 (en) | 2020-04-01 | 2021-03-26 | Formulation |
IL296898A IL296898A (en) | 2020-04-01 | 2021-03-26 | Treatment |
IL296909A IL296909A (en) | 2020-04-01 | 2021-03-26 | Formulation |
BR112022019519A BR112022019519A2 (en) | 2020-04-01 | 2021-03-26 | TREATMENT |
EP21715582.9A EP4125804A1 (en) | 2020-04-01 | 2021-03-26 | Treatment |
PCT/EP2021/058046 WO2021198115A1 (en) | 2020-04-01 | 2021-03-26 | Treatment |
US17/330,067 US11324708B1 (en) | 2020-04-01 | 2021-05-25 | Niclosamide formulations for treating disease |
US17/723,079 US20220323384A1 (en) | 2020-04-01 | 2022-04-18 | Niclosamide formulations for treating disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2010573.0A GB202010573D0 (en) | 2020-07-09 | 2020-07-09 | Formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202010573D0 true GB202010573D0 (en) | 2020-08-26 |
Family
ID=72140074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2010573.0A Ceased GB202010573D0 (en) | 2020-04-01 | 2020-07-09 | Formulation |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202010573D0 (en) |
-
2020
- 2020-07-09 GB GBGB2010573.0A patent/GB202010573D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202007546D0 (en) | Formulation | |
GB201902551D0 (en) | Formulation | |
GB201913232D0 (en) | Aerosolisable formulation | |
GB2599912B (en) | New formulation | |
GB2595300B (en) | Novel Formulation | |
GB2595453B (en) | Novel Formulation | |
IL307849A (en) | Sotorasib formulation | |
IL308046A (en) | Alpelisib formulation | |
GB202108165D0 (en) | Formulation | |
GB202107439D0 (en) | Formulation | |
GB202107203D0 (en) | Formulation | |
GB202103970D0 (en) | Formulation | |
GB202102636D0 (en) | Formulation | |
GB202102408D0 (en) | Formulation | |
GB202016274D0 (en) | Formulation | |
GB202010573D0 (en) | Formulation | |
GB202006008D0 (en) | Aerosolisable formulation | |
GB202005340D0 (en) | Formulation | |
GB202003048D0 (en) | Formulation | |
IL305977A (en) | Formulation comprising ceralasertib | |
GB202115303D0 (en) | New formulation | |
GB202108181D0 (en) | New formulation | |
GB202007620D0 (en) | Novel formulation | |
GB202318884D0 (en) | Formulation | |
GB202316857D0 (en) | Cannabinoid-based formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |